Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

January 2022; Volume 42,Issue 1

Reviews

  • You have access
    Prospects of Improving Early Ovarian Cancer Diagnosis Using Cervical Cell Swabs
    EDYTA BISKUP, REGITZE SOLLING WILS, CLAUS HOGDALL and ESTRID HOGDALL
    Anticancer Research January 2022, 42 (1) 1-12; DOI: https://doi.org/10.21873/anticanres.15451
  • You have access
    Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review
    MIKLOS ACS, POMPILIU PISO and SONIA PRADER
    Anticancer Research January 2022, 42 (1) 13-24; DOI: https://doi.org/10.21873/anticanres.15452
  • You have access
    The Role of Surgery in the Treatment of Metachronous Liver Metastasis from Gastric Cancer: A Systematic Review
    PAOLO AURELLO, ANDREA MINERVINI, MARCO PACE, FRANCESCO D’ANGELO, GIUSEPPE NIGRI, LAURA ANTOLINO, STEFANO VALABREGA, GIOVANNI RAMACCIATO and NICCOLÒ PETRUCCIANI
    Anticancer Research January 2022, 42 (1) 25-33; DOI: https://doi.org/10.21873/anticanres.15453
  • You have access
    Conversion Surgery for Hepatocellular Carcinoma Following Molecular Therapy
    KENSUKE YAMAMURA, TORU BEPPU, TATSUNORI MIYATA, HIROHISA OKABE, HIDETOSHI NITTA, KATSUNORI IMAI, HIROMITSU HAYASHI and SHINICHI AKAHOSHI
    Anticancer Research January 2022, 42 (1) 35-44; DOI: https://doi.org/10.21873/anticanres.15454
  • You have access
    Fatigue in Cancer Treatment Studies: Analysis of Placebo Arms
    HOLGER HAUCH, BIRTE J. WOLFF and JOHANNES E. WOLFF
    Anticancer Research January 2022, 42 (1) 45-52; DOI: https://doi.org/10.21873/anticanres.15455

Clinical Studies

  • You have access
    Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole Breast Irradiation
    MUTLAY SAYAN, ZEINAB ABOU YEHIA, IMRAAN JAN, APAR GUPTA, IRINA VERGALASOVA, MARC REVIELLO, SHICHA KUMAR, BRUCE HAFFTY and NISHA OHRI
    Anticancer Research January 2022, 42 (1) 53-57; DOI: https://doi.org/10.21873/anticanres.15456
  • You have access
    Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer
    MOHAMMED AL-JUMAYLI, KHALIL CHOUCAIR, AMMAR AL-OBAIDI, ROBIN PARK, AJAY BANSAL, JOAQUINA BARANDA, WEIJING SUN and ANWAAR SAEED
    Anticancer Research January 2022, 42 (1) 59-66; DOI: https://doi.org/10.21873/anticanres.15457
  • You have access
    Determinative Structural Features Identified With Probe-based Confocal Endomicroscopy for the Accurate Diagnosis of Gallbladder Malignancy
    TOMOTAKE KOIZUMI, TAKESHI AOKI, TOSHIKO YAMOCHI, YOSHIHIKO TASHIRO, TATSUYA YAMAZAKI, TOMOKAZU KUSANO, KAZUHIRO MATSUDA, YUSUKE WADA, HIDEKI SHIBATA, KAZUHIKO SAITO, KOJI NOGAKI, TOMOKI HAKOZAKI, KODAI TOMIOKA, TAKAHITO HIRAI, AKIRA FUJIMORI, DOAA A. MANSOUR, AHMED ELEWA ABBAS GAHIN and ROBERT M. HOFFMAN
    Anticancer Research January 2022, 42 (1) 67-73; DOI: https://doi.org/10.21873/anticanres.15458
  • You have access
    Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma
    JOEL CARDENAS-GOICOECHEA, YU WANG, JI-HYUN LEE, MASSOUD SHORAKA, SEMIRAMIS L. CARBAJAL-MAMANI, DAVID FISHMAN, ANDREA N. RINER and JOSE G. TREVINO
    Anticancer Research January 2022, 42 (1) 75-85; DOI: https://doi.org/10.21873/anticanres.15459
  • You have access
    Health-related Quality of Life in Intermediate- or High-risk Patients Treated With Radical External Radiotherapy and Adjuvant Docetaxel for Localized Prostate Cancer: A Randomized, Phase III SPCG-13 Study
    MIIKKA LEHTONEN, JORMA SORMUNEN, MARIE HJÄLM-ERIKSSON, CAMILLA THELLENBERG-KARLSSON, TEPPO HUTTUNEN, CLAES GINMAN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and On Behalf of the Investigators of the Scandinavian Prostate Cancer Group Study No 13
    Anticancer Research January 2022, 42 (1) 87-92; DOI: https://doi.org/10.21873/anticanres.15460
  • You have access
    Toxicities and Locoregional Control After External Beam Chest Wall and/or Regional Lymph Node Re-irradiation for Recurrent Breast Cancer
    MUTLAY SAYAN, IRINA VERGALASOVA, IMRAAN JAN, SHICHA KUMAR, NANCY CHAN, BRUCE G. HAFFTY and NISHA OHRI
    Anticancer Research January 2022, 42 (1) 93-96; DOI: https://doi.org/10.21873/anticanres.15461
  • You have access
    The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1)
    UBAI ALSHARIF, DANIEL STELLER, MOHAMED FALOUGY, LARS THARUN, DIRK RADES and SAMER G. HAKIM
    Anticancer Research January 2022, 42 (1) 97-104; DOI: https://doi.org/10.21873/anticanres.15462
  • You have access
    Preoperative Risk Factors for Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans
    KATHERINE E. MALLETT, SARAH ALMUBARAK, RYAN M. CLAXTON, PETER C. FERGUSON, ANTHONY M. GRIFFIN, PETER S. ROSE, JAY S. WUNDER, KIM TSOI and MATTHEW T. HOUDEK
    Anticancer Research January 2022, 42 (1) 105-108; DOI: https://doi.org/10.21873/anticanres.15463
  • You have access
    Prevalence of Diabetes and Impaired Fasting Glycemia in Patients With Oral Cancer: A Retrospective Study in Hungary
    ADAM VEGH, DOROTTYA BANYAI, MARTA UJPAL, KATA SARA SOMOGYI, ZITA BICZO, GABOR KAMMERHOFER, ZSOLT NEMETH, PETER HERMANN, MICHAEL PAYER and DANIEL VEGH
    Anticancer Research January 2022, 42 (1) 109-113; DOI: https://doi.org/10.21873/anticanres.15464
  • You have access
    Scoring Systems of Peritoneal Dissemination for the Prediction of Operative Completeness in Advanced Ovarian Cancer
    SATOSHI HOSOYA, KAZU UEDA, SUGURU ODAJIMA, KOHEI OGAWA, HIROMI KOMAZAKI, TOSHIYUKI SEKI, MASATAKA TAKENAKA, MOTOAKI SAITO, HIROSHI TANABE, KYOSUKE YAMADA, HIROKUNI TAKANO, YASUSHI IIDA, NOZOMU YANAIHARA and AIKOU OKAMOTO
    Anticancer Research January 2022, 42 (1) 115-124; DOI: https://doi.org/10.21873/anticanres.15465
  • You have access
    Clinical Significance of Expression of Immunoadjuvant Molecules (LAG-3, TIM-3, OX-40) in Neoadjuvant Chemotherapy for Breast Cancer
    YUKA ASANO, SHINICHIRO KASHIWAGI, KOJI TAKADA, SAE ISHIHARA, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research January 2022, 42 (1) 125-136; DOI: https://doi.org/10.21873/anticanres.15466
  • You have access
    Clinical Impact of CYFRA 21-1 a Marker for Treatment Failure in Patients With Oropharyngeal Cancer Treated by Radio(chemo)therapy
    STEFAN A. RUDHART, PHILIPP LANGEN, KRUTHIKA THANGAVELU, FRANCESCA GEHRT, PETAR STANKOVIC, THOMAS WILHELM, BORIS A. STUCK and STEPHAN HOCH
    Anticancer Research January 2022, 42 (1) 137-146; DOI: https://doi.org/10.21873/anticanres.15467
  • You have access
    Diagnostic and Prognostic Impact of Crypt Branching in Patients With Ulcerative Colitis: A Validation Study
    CORINNA LANG-SCHWARZ, CARLOS A. RUBIO and MICHAEL VIETH
    Anticancer Research January 2022, 42 (1) 147-154; DOI: https://doi.org/10.21873/anticanres.15468
  • You have access
    Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma
    OLIVIER MULLER, REMY SINDAYIGAYA, SANDRA CHOMICKI, ELIAS KARAM, NICOLAS TABCHOURI, NICOLAS MICHOT, DRIFFA MOUSSATA, THIERRY LECOMTE, SOPHIE CHAPET, GILLES CALAIS, URS GIGER-PABST, EPHREM SALAME and MEHDI OUAISSI
    Anticancer Research January 2022, 42 (1) 155-164; DOI: https://doi.org/10.21873/anticanres.15469
  • You have access
    The Role of Fast and Deep PSA Response in Castration-sensitive Prostate Cancer
    ROBERTO IACOVELLI, CHIARA CICCARESE, ORAZIO CAFFO, UGO DE GIORGI, UMBERTO BASSO, MARCELLO TUCCI, CLAUDIA MOSILLO, MARCO MARUZZO, FRANCESCA MAINES, CHIARA CASADEI, MICHELE MILELLA and GIAMPAOLO TORTORA
    Anticancer Research January 2022, 42 (1) 165-172; DOI: https://doi.org/10.21873/anticanres.15470
  • You have access
    Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    NAOTAKA SHIMOZATO, TADASHI NAMISAKI, AKIHIRO OKANO, MASAYA OHANA, DAISUKE KINOSHITA, TOSHIHIKO KAWASAKI, YOSUKE AIHARA, TOSHIYA NAKATANI, HIROKI KINOSHITA, TATSUICHI ANN, KO SAITO, MOTOYUKI YOSHIDA and HITOSHI YOSHIJI
    Anticancer Research January 2022, 42 (1) 173-183; DOI: https://doi.org/10.21873/anticanres.15471
  • You have access
    Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma
    STANISLAS QUESADA, EMMANUELLE SAMALIN, SIMON THEZENAS, LAKHDAR KHELLAF, ANNE MOURREGOT, FABIENNE PORTALES, THIBAULT MAZARD, MARC YCHOU and ANTOINE ADENIS
    Anticancer Research January 2022, 42 (1) 185-193; DOI: https://doi.org/10.21873/anticanres.15472
  • You have access
    ypN0 in Patients With Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer
    TAKAHIRO YOSHIDA, TAKESHI NISHINO, MASAKAZU GOTO, SEIYA INOUE, SATOSHI FUJIWARA, HIROMITSU TAKIZAWA, AKIRA TANGOKU, HISANORI UEHARA and YOSHIMI BANDO
    Anticancer Research January 2022, 42 (1) 195-203; DOI: https://doi.org/10.21873/anticanres.15473
  • You have access
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation
    RYO TOYA, TAKAHIRO WATAKABE, DAIZO MURAKAMI, TOMOHIKO MATSUYAMA, TETSUO SAITO, YOSHIYUKI FUKUGAWA, KOHEI NISHIMOTO, YORIHISA ORITA and NATSUO OYA
    Anticancer Research January 2022, 42 (1) 205-209; DOI: https://doi.org/10.21873/anticanres.15474
  • You have access
    The Role of Indocyanine Green in Laparoscopic Low Anterior Resections for Rectal Cancer Previously Treated With Chemo-radiotherapy: A Single-center Retrospective Analysis
    ANTONIO BRESCIA, EDOARDO MARIA MUTTILLO, ILARIA ANGELICONE, ISABELLA MADAFFARI, FEDERICO MAGGI, ISABELLA SPERDUTI, MARCELLO GASPARRINI and MATTIA FALCHETTO OSTI
    Anticancer Research January 2022, 42 (1) 211-216; DOI: https://doi.org/10.21873/anticanres.15475
  • You have access
    Pancreatectomy With Artery En-bloc Resection for Pancreatic Neck/Body Cancer: A Single-arm Pilot Study
    KEN-ICHI OKADA, MANABU KAWAI, SEIKO HIRONO, SHINYA HAYAMI, MOTOKI MIYAZAWA, YUJI KITAHATA, MASAKI UENO, RYOHEI KOBAYASHI, ATSUSHI MIYAMOTO, YOSHITAKA WADA, SHINICHI ASAMURA and HIROKI YAMAUE
    Anticancer Research January 2022, 42 (1) 217-227; DOI: https://doi.org/10.21873/anticanres.15476
  • You have access
    Impact of Tumor Growth Speed of Primary Lesions on the Clinical Outcomes of Appendicular Skeletal Metastases
    YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, HIROTAKA YONEZAWA, YOSHIHIRO ARAKI, SEI MORINAGA, SHIRO SAITO, TAKAYUKI NOJIMA and HIROYUKI TSUCHIYA
    Anticancer Research January 2022, 42 (1) 229-236; DOI: https://doi.org/10.21873/anticanres.15477
  • You have access
    Tumor Location on the Vertical Section of the Anterior Wall Is Related to Favorable Prognosis and Low Incidence of Lymph Node Metastasis in Lower-third Gastric Cancer
    YUSUKE TAKASHIMA, SHUHEI KOMATSU, MASATAKA KASUGA, TAKUMA OHASHI, HIROTAKA KONISHI, ATSUSHI SHIOZAKI, TAKESHI KUBOTA, HITOSHI FUJIWARA, KAZUMA OKAMOTO and EIGO OTSUJI
    Anticancer Research January 2022, 42 (1) 237-243; DOI: https://doi.org/10.21873/anticanres.15478
  • You have access
    Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response
    NORIFUMI HARIMOTO, SHINJI ITOH, TAKAHIRO YAMANAKA, KEI HAGIWARA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, AKIRA WATANABE, KENICHIRO ARAKI, TOMOHARU YOSHIZUMI and KEN SHIRABE
    Anticancer Research January 2022, 42 (1) 245-251; DOI: https://doi.org/10.21873/anticanres.15479
  • You have access
    Thyroid Hormones and Morphological Features of Primary Breast Cancer
    AMICHAY MEIROVITZ, BENJAMIN NISMAN, TANIR M. ALLWEIS, EINAT CARMON, LUNA KADOURI, BELLA MALY, OFRA MAIMON and TAMAR PERETZ
    Anticancer Research January 2022, 42 (1) 253-261; DOI: https://doi.org/10.21873/anticanres.15480
  • You have access
    Prognostic Value of Squamous Differentiation in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy
    AKINORI MINATO, HIROTSUGU NOGUCHI, RIEKO KIMURO, HARADA MIRII, NAGATA YUJIRO, YOSHITAKA HASEGAWA, IKKO TOMISAKI, KENICHI HARADA and NAOHIRO FUJIMOTO
    Anticancer Research January 2022, 42 (1) 263-269; DOI: https://doi.org/10.21873/anticanres.15481
  • You have access
    Chloride Intracellular Channel 1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma
    YUICHIRO YASUDA, TATSUYA NAGANO, NAOE JIMBO, TATSUNORI KIRIU, RATOE SURAYA, DAISUKE HAZAMA, MASATSUGU YAMAMOTO, YOSHIMASA MANIWA, YOSHIHIRO NISHIMURA and KAZUYUKI KOBAYASHI
    Anticancer Research January 2022, 42 (1) 271-277; DOI: https://doi.org/10.21873/anticanres.15482
  • You have access
    Clinical Significance of Serglycin Expression in Human Breast Cancer Patients
    KEIKO HOSOYA, KANAE NOSAKA, TOMOHIKO SAKABE, MAKOTO WAKAHARA, YUKI OSHIMA, YOSHIMASA SUZUKI, HIROSHIGE NAKAMURA and YOSHIHISA UMEKITA
    Anticancer Research January 2022, 42 (1) 279-285; DOI: https://doi.org/10.21873/anticanres.15483
  • You have access
    Predictive Factors of Late Cervical Lymph Node Metastasis Using Intraoral Sonography in Patients With Tongue Cancer
    MASARU KONISHI, MINORU FUJITA, KIICHI SHIMABUKURO, PONGSAPAK WONGRATWANICH and NAOYA KAKIMOTO
    Anticancer Research January 2022, 42 (1) 287-292; DOI: https://doi.org/10.21873/anticanres.15484
  • You have access
    Reirradiation Using 198Au Grain Brachytherapy for Recurrent Oral Cancer Cases Previously Treated by Definitive Radiotherapy
    MASARU KONISHI, YUKI TAKEUCHI, KATSUMARO KUBO, NOBUKI IMANO, IKUNO NISHIBUCHI, YUJI MURAKAMI, KIICHI SHIMABUKURO, PONGSAPAK WONGRATWANICH, NAOYA KAKIMOTO and YASUSHI NAGATA
    Anticancer Research January 2022, 42 (1) 293-300; DOI: https://doi.org/10.21873/anticanres.15485
  • You have access
    Preoperative Masseter Muscle Sarcopenia Predicts Mortality in Patients With Oesophageal Cancer
    TEPPEI KAMADA, HIRONORI OHDAIRA, EISAKU ITO, YOSHINOBU FUSE, JUNJI TAKAHASHI, KEIGO NAKASHIMA, YUICHI NAKASEKO, MASASHI YOSHIDA, KEN ETO and YUTAKA SUZUKI
    Anticancer Research January 2022, 42 (1) 301-310; DOI: https://doi.org/10.21873/anticanres.15486
  • You have access
    The Effect of Smoking on Progression from Ductal Carcinoma In Situ to Invasive Ductal Breast Carcinoma: A Retrospective Study
    KOJI TAKADA, SHINICHIRO KASHIWAGI, YUKA ASANO, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research January 2022, 42 (1) 311-320; DOI: https://doi.org/10.21873/anticanres.15487
  • You have access
    Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective Analysis
    KAZUHIKO HAYASHI, OSAMU SUZUKI, HIROYA SHIOMI, MASATAKA NAKAI, KEI FUJIWARA, ERINA NAKANISHI, SHOTARO TATEKAWA, TAKERO HIRATA, KEISUKE TAMARI, HARUHIKO HIRATA, SOICHIRO FUNAKI, YUJI SEO, YOSHITO TAKEDA, FUMIAKI ISOHASHI, YASUSHI SHINTANI and KAZUHIKO OGAWA
    Anticancer Research January 2022, 42 (1) 321-327; DOI: https://doi.org/10.21873/anticanres.15488
  • You have access
    Multiparametric MRI-guided Hypofractionated Intensity-modulated Radiation Therapy With Simultaneous Integrated Boost for Glioblastoma
    YUKIHIRO HAMA and ETSUKO TATE
    Anticancer Research January 2022, 42 (1) 329-334; DOI: https://doi.org/10.21873/anticanres.15489
  • You have access
    Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma
    MOONSIK KIM, JIHWAN YOO, JONG HEE CHANG and SE HOON KIM
    Anticancer Research January 2022, 42 (1) 335-341; DOI: https://doi.org/10.21873/anticanres.15490
  • You have access
    A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular Pain
    KAZUKI UCHIYAMA, YOSHITAKA SAITO, TATSUHIKO SAKAMOTO, YOH TAKEKUMA, YOSHITO KOMATSU and MITSURU SUGAWARA
    Anticancer Research January 2022, 42 (1) 343-348; DOI: https://doi.org/10.21873/anticanres.15491
  • You have access
    Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
    JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG
    Anticancer Research January 2022, 42 (1) 349-353; DOI: https://doi.org/10.21873/anticanres.15492
  • You have access
    Prognostic Value of Copine 1 in Patients With Renal Cell Carcinoma
    IMAN M. TALAAT, EMAN ABU-GHARBIEH, AMAL HUSSEIN, MAHMOOD HACHIM, ISRAA SOBHY, MOHAMED ELADL and WASEEM EL-HUNEIDI
    Anticancer Research January 2022, 42 (1) 355-362; DOI: https://doi.org/10.21873/anticanres.15493
  • You have access
    The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study
    EUN JI LEE, SOO JIN PARK, JEESUN LEE, JAEHEE MUN, HAERIN PAIK, AERAN SEOL, JUNHWAN KIM, GA WON YIM, SEUNG-HYUK SHIM, HEE SEUNG KIM, SUK-JOON CHANG and on behalf of the KoRIA Trial Group
    Anticancer Research January 2022, 42 (1) 363-371; DOI: https://doi.org/10.21873/anticanres.15494
  • You have access
    Excellent Response to MEK Inhibition in an AGK-BRAF Gene Fusion Driven Carcinoma: Case Report and Literature Review
    ANDREAS DOMEN, CARL VAN PAESSCHEN, KAREN ZWAENEPOEL, SUZAN LAMBIN, PATRICK PAUWELS, MARIKA RASSCHAERT, EVA SEGELOV, MARC PEETERS and HANS PRENEN
    Anticancer Research January 2022, 42 (1) 373-379; DOI: https://doi.org/10.21873/anticanres.15495
  • You have access
    A Case of Mesenteric Desmoid Tumor Causing Bowel Obstruction After Laparoscopic Surgery
    KOTA ARIMA, YOSHIHIRO KOMOHARA, TOMOYUKI UCHIHARA, KOHEI YAMASHITA, SHINICHIRO UEMURA, NORIHISA HANADA and HIDEO BABA
    Anticancer Research January 2022, 42 (1) 381-384; DOI: https://doi.org/10.21873/anticanres.15496

Experimental Studies

  • You have access
    A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy
    JUNAN LI, AVINASH K. PERSAUD, JASMINE A. JOHNSON, DOUGKAS W. SBOROV, MITCH A. PHELPS, CRAIG C. HOFMEISTER and MING J. POI
    Anticancer Research January 2022, 42 (1) 385-395; DOI: https://doi.org/10.21873/anticanres.15497
  • You have access
    Moderate Intensity Endurance and Resistance Exercise Attenuates Cachexia in Tumor-bearing Mice
    NICOLE R. WOOD, JACOB GARRITSON, ALISSA MATHIAS, JAMES M. HAUGHIAN and REID HAYWARD
    Anticancer Research January 2022, 42 (1) 397-405; DOI: https://doi.org/10.21873/anticanres.15498
  • You have access
    High-purity Isolation for Genotyping Rare Cancer Cells from Blood Using a Microfluidic Chip Cell Sorter
    MIO IKEDA, YASUHIRO KOH, JUN OYANAGI, SHUNSUKE TERAOKA, MASAYUKI ISHIGE, YUU FUJIMURA, KAZUO TAKEDA, NAHOMI TOKUDOME, YUICHI OZAWA, HIROKI UEDA and NOBUYUKI YAMAMOTO
    Anticancer Research January 2022, 42 (1) 407-417; DOI: https://doi.org/10.21873/anticanres.15499
  • You have access
    Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software
    HARUO MIYATA, YASUTO AKIYAMA, AKIRA IIZUKA, RYOTA KONDOU, CHIE MAEDA, AKARI KANEMATSU, KYOKO WATANABE, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KENICHI URAKAMI, KEIICHI OHSHIMA, TAKUYA KAWATA, KOJI MURAMATSU, AKIO SHIOMI, MASANORI TERASHIMA, TAKASHI SUGINO, AKIFUMI NOTSU, KEITA MORI and KEN YAMAGUCHI
    Anticancer Research January 2022, 42 (1) 419-427; DOI: https://doi.org/10.21873/anticanres.15500
  • You have access
    MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung Cancer
    BETTINA SAVARESE-BRENNER, MARLENE HEUGL, BARBARA RATH, CONRADIN SCHWEIZER, EVA OBERMAYR, SANDRA STICKLER and GERHARD HAMILTON
    Anticancer Research January 2022, 42 (1) 429-439; DOI: https://doi.org/10.21873/anticanres.15501
  • You have access
    A Rare Presentation of a Non-Asian Female With Metastatic Non-small-cell Lung Cancer Harboring EGFR L747P Mutation With Clinical Response to Multi-targeted Epigenetic and EGFR Inhibition
    SAMIA S. MESSEHA, MOHAMMAD A. NEZAMI, STEVEN HAGER and KARAM F.A. SOLIMAN
    Anticancer Research January 2022, 42 (1) 441-447; DOI: https://doi.org/10.21873/anticanres.15502
  • You have access
    Clinicopathological Analysis of Non-B Non-C Hepatocellular Carcinoma Focusing on Cellular Proliferation
    SHINJI MIZUOCHI, JUN AKIBA, REIICHIRO KONDO, HIRONORI KUSANO, TARO SHIOGA, KEIICHI KONDO, KANA TSUTSUI, MASAMICHI NAKAYAMA, SACHIKO OGASAWARA, YOSHIKI NAITO, OSAMU NAKASHIMA and HIROHISA YANO
    Anticancer Research January 2022, 42 (1) 449-457; DOI: https://doi.org/10.21873/anticanres.15503
  • You have access
    CD15+ Bone Marrow-derived Cells Are Regulators of Immune Response in ARG1-producing Colorectal Cancer Cells
    KENTA MIYOSHI, EIICHI SATO, KENJI KATSUMATA, GENTARO FUKUSHIMA, RYUTARO UDO, EMI NISHIMURA, TOMOYA TAGO, KENTA KASAHARA, JUNICHI MAZAKI, MASANOBU ENOMOTO, TETSUO ISHIZAKI, YUICHI NAGAKAWA and AKIHIKO TSUCHIDA
    Anticancer Research January 2022, 42 (1) 459-470; DOI: https://doi.org/10.21873/anticanres.15504
  • You have access
    Blockade of GRP78 Translocation to the Cell Surface by HDAC6 Inhibition Suppresses Proliferation of Cholangiocarcinoma Cells
    CHORONG KIM, SEONMIN LEE, DANBEE KIM, DA SOL LEE, EUNJUNG LEE, CHANGHOON YOO and KYU-PYO KIM
    Anticancer Research January 2022, 42 (1) 471-482; DOI: https://doi.org/10.21873/anticanres.15505
  • You have access
    Eupatilin Suppresses Pancreatic Cancer Cells via Glucose Uptake Inhibition, AMPK Activation, and Cell Cycle Arrest
    TAE HYUN PARK and HYEON SOO KIM
    Anticancer Research January 2022, 42 (1) 483-491; DOI: https://doi.org/10.21873/anticanres.15506
  • You have access
    Nuclear Factor IA Is Down-regulated in Muscle-invasive and High-grade Bladder Cancers
    MACIEJ KACZOROWSKI, JOANNA MATYSIAK, PAWEL KIELB, BARTOSZ MALKIEWICZ and AGNIESZKA HALON
    Anticancer Research January 2022, 42 (1) 493-500; DOI: https://doi.org/10.21873/anticanres.15507
  • You have access
    Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells
    SHUHEI KUSHIYAMA, MASAKAZU YASHIRO, YURIE YAMAMOTO, TOMOHIRO SERA, ATSUSHI SUGIMOTO, SADAAKI NISHIMURA, SHINGO TOGANO, KENJI KURODA, TOMOHISA OKUNO, YUICHIRO MIKI and MASAICHI OHIRA
    Anticancer Research January 2022, 42 (1) 501-509; DOI: https://doi.org/10.21873/anticanres.15508
  • You have access
    Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8+ T Cells: A Study Based on The Cancer Genome Atlas (TCGA)
    SATORU YONEKURA
    Anticancer Research January 2022, 42 (1) 511-517; DOI: https://doi.org/10.21873/anticanres.15509
  • You have access
    14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion via Matrix Metalloproteinase-1 Regulation in Human Gastric Cancer
    JI YOON JUNG, SUNG AE KOH, KYUNG HEE LEE and JAE RYONG KIM
    Anticancer Research January 2022, 42 (1) 519-530; DOI: https://doi.org/10.21873/anticanres.15510
  • You have access
    Helicobacter pylori Targets in AGS Human Gastric Adenocarcinoma: In Situ Proteomic Profiling and Systematic Analysis
    JAI-SING YANG, CHIA-YU KANG, CHIU-HSIAN SU, CHAO-JUNG CHEN, YU-JEN CHIU and YUAN-MAN HSU
    Anticancer Research January 2022, 42 (1) 531-546; DOI: https://doi.org/10.21873/anticanres.15511
  • You have access
    Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes
    DONIKA IVANOVA, ZHIVKO ZHELEV, GENOVEVA ZLATEVA, DESSISLAVA LAZAROVA, ZVEZDELINA YANEVA, RADMILA PANOVSKA, ICHIO AOKI and RUMIANA BAKALOVA
    Anticancer Research January 2022, 42 (1) 547-554; DOI: https://doi.org/10.21873/anticanres.15512
  • You have access
    Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells
    SUNG HO MOON, NAM-SOOK PARK, MIN HYE NOH, YEONG SEOK KIM, SOON HO CHEONG and DAE YOUNG HUR
    Anticancer Research January 2022, 42 (1) 555-563; DOI: https://doi.org/10.21873/anticanres.15513
  • You have access
    Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen
    GABRIELLA BIANCA HENRIQUES PALMA and MANDEEP KAUR
    Anticancer Research January 2022, 42 (1) 565-579; DOI: https://doi.org/10.21873/anticanres.15514
  • You have access
    Nerve Growth Factor in Breast Cancer Cells Promotes Axonal Growth and Expression of Calcitonin Gene-related Peptide in a Rat Model of Spinal Metastasis
    AI MAZAKI, KAZUYO YAMAUCHI, SUMIHISA ORITA, KAZUHIDE INAGE, MIYAKO SUZUKI, KAZUKI FUJIMOTO, YASUHIRO SHIGA, KOHKI ABE, MASAHIRO INOUE, MASAKI NORIMOTO, TOMOTAKA UMIMURA and SEIJI OHTORI
    Anticancer Research January 2022, 42 (1) 581-587; DOI: https://doi.org/10.21873/anticanres.15515
  • You have access
    Suppression of DYRK1A/B Drives Endoplasmic Reticulum Stress-mediated Autophagic Cell Death Through Metabolic Reprogramming in Colorectal Cancer Cells
    JIEON HWANG, AREUM PARK, CHINWOO KIM, DANBI YU, HYUNGJU BYUN, MINHEE KU, JAEMOON YANG, TAE IL KIM, KYU-SUNG JEONG, KI YOUNG KIM, HYUK LEE and SANG JOON SHIN
    Anticancer Research January 2022, 42 (1) 589-598; DOI: https://doi.org/10.21873/anticanres.15516
  • You have access
    Establishment of Patient-derived Preclinical Models for Invasive Papillary Cholangiocarcinoma
    BENJAMIN MWESIGE, MI RIM LEE, YU-SUN LEE, NA YOUNG HAN, JI EUN IM, JOON-KI KIM, SUN IL CHOI, EN KYUNG HONG, A-RA JEON, SANG-JAE PARK, SANG MYUNG WOO and YUN-HEE KIM
    Anticancer Research January 2022, 42 (1) 599-608; DOI: https://doi.org/10.21873/anticanres.15517
  • You have access
    Development of Non-alcoholic Steatohepatitis and Nodular Regenerative Hyperplasia in C57BL/6J Mice Fed a Fructose-containing Western Diet
    KEN-ICHI INOUE, HIDETSUGU YAMAGISHI, TERUO JOJIMA, TERUO INOUE and SHIGERU TOYODA
    Anticancer Research January 2022, 42 (1) 609-617; DOI: https://doi.org/10.21873/anticanres.15518
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (1)
Anticancer Research
Vol. 42, Issue 1
January 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole Breast Irradiation
  • Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma
  • Health-related Quality of Life in Intermediate- or High-risk Patients Treated With Radical External Radiotherapy and Adjuvant Docetaxel for Localized Prostate Cancer: A Randomized, Phase III SPCG-13 Study
  • A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy
  • Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software
Sign up for alerts

Jump to

  • Reviews
  • Clinical Studies
  • Experimental Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire